nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Ocular hyperaemia—Tretinoin—peripheral nervous system neoplasm	0.0367	0.0387	CcSEcCtD
Naphazoline—Ocular hyperaemia—Isotretinoin—peripheral nervous system neoplasm	0.0367	0.0387	CcSEcCtD
Naphazoline—Endophthalmitis—Tretinoin—peripheral nervous system neoplasm	0.0362	0.0381	CcSEcCtD
Naphazoline—Endophthalmitis—Isotretinoin—peripheral nervous system neoplasm	0.0362	0.0381	CcSEcCtD
Naphazoline—NISCH—Podofilox—Etoposide—peripheral nervous system neoplasm	0.0297	0.592	CbGdCrCtD
Naphazoline—Ocular hyperaemia—Alitretinoin—peripheral nervous system neoplasm	0.0278	0.0293	CcSEcCtD
Naphazoline—Endophthalmitis—Alitretinoin—peripheral nervous system neoplasm	0.0274	0.0288	CcSEcCtD
Naphazoline—Keratitis—Tretinoin—peripheral nervous system neoplasm	0.0265	0.0279	CcSEcCtD
Naphazoline—Keratitis—Isotretinoin—peripheral nervous system neoplasm	0.0265	0.0279	CcSEcCtD
Naphazoline—Redness—Tretinoin—peripheral nervous system neoplasm	0.0255	0.0268	CcSEcCtD
Naphazoline—Redness—Isotretinoin—peripheral nervous system neoplasm	0.0255	0.0268	CcSEcCtD
Naphazoline—NISCH—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.0204	0.408	CbGdCrCtD
Naphazoline—Keratitis—Alitretinoin—peripheral nervous system neoplasm	0.0201	0.0212	CcSEcCtD
Naphazoline—Redness—Alitretinoin—peripheral nervous system neoplasm	0.0193	0.0203	CcSEcCtD
Naphazoline—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.0187	0.0197	CcSEcCtD
Naphazoline—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.0187	0.0197	CcSEcCtD
Naphazoline—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.0142	0.0149	CcSEcCtD
Naphazoline—Lacrimation—Epirubicin—peripheral nervous system neoplasm	0.00971	0.0102	CcSEcCtD
Naphazoline—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00963	0.0101	CcSEcCtD
Naphazoline—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00963	0.0101	CcSEcCtD
Naphazoline—Sweating—Topotecan—peripheral nervous system neoplasm	0.00931	0.0098	CcSEcCtD
Naphazoline—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00923	0.00972	CcSEcCtD
Naphazoline—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00923	0.00972	CcSEcCtD
Naphazoline—Lacrimation—Doxorubicin—peripheral nervous system neoplasm	0.00898	0.00946	CcSEcCtD
Naphazoline—Keratitis—Epirubicin—peripheral nervous system neoplasm	0.0088	0.00927	CcSEcCtD
Naphazoline—Redness—Epirubicin—peripheral nervous system neoplasm	0.00846	0.0089	CcSEcCtD
Naphazoline—Keratitis—Doxorubicin—peripheral nervous system neoplasm	0.00814	0.00857	CcSEcCtD
Naphazoline—Eye disorder—Tretinoin—peripheral nervous system neoplasm	0.00808	0.00851	CcSEcCtD
Naphazoline—Eye disorder—Isotretinoin—peripheral nervous system neoplasm	0.00808	0.00851	CcSEcCtD
Naphazoline—Redness—Doxorubicin—peripheral nervous system neoplasm	0.00782	0.00824	CcSEcCtD
Naphazoline—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00753	0.00792	CcSEcCtD
Naphazoline—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00753	0.00792	CcSEcCtD
Naphazoline—Tension—Tretinoin—peripheral nervous system neoplasm	0.00739	0.00777	CcSEcCtD
Naphazoline—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00739	0.00777	CcSEcCtD
Naphazoline—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00731	0.0077	CcSEcCtD
Naphazoline—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00731	0.0077	CcSEcCtD
Naphazoline—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.0073	0.00768	CcSEcCtD
Naphazoline—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00709	0.00747	CcSEcCtD
Naphazoline—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00709	0.00747	CcSEcCtD
Naphazoline—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.007	0.00737	CcSEcCtD
Naphazoline—Sweating—Vincristine—peripheral nervous system neoplasm	0.00674	0.0071	CcSEcCtD
Naphazoline—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.0065	0.00684	CcSEcCtD
Naphazoline—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.0065	0.00684	CcSEcCtD
Naphazoline—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00638	0.00672	CcSEcCtD
Naphazoline—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00633	0.00666	CcSEcCtD
Naphazoline—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00633	0.00666	CcSEcCtD
Naphazoline—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.00619	0.00652	CcSEcCtD
Naphazoline—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00615	0.00648	CcSEcCtD
Naphazoline—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.00612	0.00645	CcSEcCtD
Naphazoline—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00599	0.0063	CcSEcCtD
Naphazoline—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00594	0.00625	CcSEcCtD
Naphazoline—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00594	0.00625	CcSEcCtD
Naphazoline—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00573	0.00603	CcSEcCtD
Naphazoline—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.0057	0.006	CcSEcCtD
Naphazoline—Tension—Alitretinoin—peripheral nervous system neoplasm	0.0056	0.00589	CcSEcCtD
Naphazoline—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00554	0.00583	CcSEcCtD
Naphazoline—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00546	0.00575	CcSEcCtD
Naphazoline—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00546	0.00575	CcSEcCtD
Naphazoline—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00538	0.00566	CcSEcCtD
Naphazoline—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00522	0.00549	CcSEcCtD
Naphazoline—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00517	0.00545	CcSEcCtD
Naphazoline—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00492	0.00518	CcSEcCtD
Naphazoline—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00486	0.00512	CcSEcCtD
Naphazoline—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.0048	0.00505	CcSEcCtD
Naphazoline—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00478	0.00503	CcSEcCtD
Naphazoline—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00475	0.005	CcSEcCtD
Naphazoline—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00459	0.00483	CcSEcCtD
Naphazoline—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00458	0.00482	CcSEcCtD
Naphazoline—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.0045	0.00474	CcSEcCtD
Naphazoline—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00444	0.00468	CcSEcCtD
Naphazoline—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00441	0.00464	CcSEcCtD
Naphazoline—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00441	0.00464	CcSEcCtD
Naphazoline—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00435	0.00458	CcSEcCtD
Naphazoline—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00434	0.00456	CcSEcCtD
Naphazoline—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00425	0.00447	CcSEcCtD
Naphazoline—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00414	0.00436	CcSEcCtD
Naphazoline—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00409	0.00431	CcSEcCtD
Naphazoline—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00409	0.0043	CcSEcCtD
Naphazoline—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00406	0.00428	CcSEcCtD
Naphazoline—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00406	0.00428	CcSEcCtD
Naphazoline—Headache—Topotecan—peripheral nervous system neoplasm	0.00388	0.00408	CcSEcCtD
Naphazoline—Headache—Tretinoin—peripheral nervous system neoplasm	0.00385	0.00405	CcSEcCtD
Naphazoline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00385	0.00405	CcSEcCtD
Naphazoline—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00384	0.00405	CcSEcCtD
Naphazoline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00383	0.00404	CcSEcCtD
Naphazoline—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00374	0.00394	CcSEcCtD
Naphazoline—Nausea—Topotecan—peripheral nervous system neoplasm	0.00368	0.00387	CcSEcCtD
Naphazoline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00365	0.00384	CcSEcCtD
Naphazoline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00365	0.00384	CcSEcCtD
Naphazoline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.0036	0.00379	CcSEcCtD
Naphazoline—Nausea—Melphalan—peripheral nervous system neoplasm	0.0036	0.00379	CcSEcCtD
Naphazoline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00351	0.0037	CcSEcCtD
Naphazoline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00334	0.00352	CcSEcCtD
Naphazoline—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00323	0.0034	CcSEcCtD
Naphazoline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00323	0.0034	CcSEcCtD
Naphazoline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00322	0.00339	CcSEcCtD
Naphazoline—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00319	0.00336	CcSEcCtD
Naphazoline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00308	0.00324	CcSEcCtD
Naphazoline—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00306	0.00322	CcSEcCtD
Naphazoline—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00299	0.00315	CcSEcCtD
Naphazoline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00298	0.00314	CcSEcCtD
Naphazoline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00297	0.00312	CcSEcCtD
Naphazoline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00295	0.00311	CcSEcCtD
Naphazoline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00292	0.00307	CcSEcCtD
Naphazoline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00285	0.003	CcSEcCtD
Naphazoline—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00283	0.00298	CcSEcCtD
Naphazoline—Headache—Vincristine—peripheral nervous system neoplasm	0.00281	0.00296	CcSEcCtD
Naphazoline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00276	0.00291	CcSEcCtD
Naphazoline—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00268	0.00282	CcSEcCtD
Naphazoline—Nausea—Vincristine—peripheral nervous system neoplasm	0.00266	0.0028	CcSEcCtD
Naphazoline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00261	0.00274	CcSEcCtD
Naphazoline—Erythema—Epirubicin—peripheral nervous system neoplasm	0.0025	0.00263	CcSEcCtD
Naphazoline—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00248	0.00261	CcSEcCtD
Naphazoline—Tension—Epirubicin—peripheral nervous system neoplasm	0.00245	0.00258	CcSEcCtD
Naphazoline—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00242	0.00255	CcSEcCtD
Naphazoline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.0024	0.00253	CcSEcCtD
Naphazoline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00236	0.00248	CcSEcCtD
Naphazoline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00235	0.00248	CcSEcCtD
Naphazoline—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00231	0.00243	CcSEcCtD
Naphazoline—Headache—Etoposide—peripheral nervous system neoplasm	0.00228	0.0024	CcSEcCtD
Naphazoline—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00227	0.00239	CcSEcCtD
Naphazoline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00224	0.00236	CcSEcCtD
Naphazoline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00218	0.00229	CcSEcCtD
Naphazoline—Nausea—Etoposide—peripheral nervous system neoplasm	0.00216	0.00227	CcSEcCtD
Naphazoline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00215	0.00227	CcSEcCtD
Naphazoline—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.0021	0.00221	CcSEcCtD
Naphazoline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00199	0.0021	CcSEcCtD
Naphazoline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00207	CcSEcCtD
Naphazoline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00194	0.00204	CcSEcCtD
Naphazoline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00192	CcSEcCtD
Naphazoline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00181	0.00191	CcSEcCtD
Naphazoline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Naphazoline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00154	CcSEcCtD
Naphazoline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00142	CcSEcCtD
Naphazoline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00142	CcSEcCtD
Naphazoline—Headache—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00134	CcSEcCtD
Naphazoline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00131	CcSEcCtD
Naphazoline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00127	CcSEcCtD
Naphazoline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00124	CcSEcCtD
Naphazoline—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00118	CcSEcCtD
